AI in Biotech R&D Market Accelerates Innovation and Transforms Drug Discovery Landscape
Read More: https://researchintelo.com/rep....ort/ai-in-biotech-rd
According to our latest research, the Global AI in Biotech R&D market size was valued at $2.7 billion in 2024 and is projected to reach $16.4 billion by 2033, expanding at a robust CAGR of 22.1% during 2024–2033. This remarkable growth trajectory is primarily driven by the rapid integration of advanced artificial intelligence technologies into the biotech research and development lifecycle, enabling unprecedented acceleration in drug discovery, genomics, and precision medicine. The synergy between AI algorithms and high-throughput biological data is transforming traditional R&D paradigms, reducing both time and cost while enhancing the accuracy and efficacy of outcomes. As the demand for innovative therapies and personalized medicine continues to rise globally, the AI in Biotech R&D market is set to experience exponential expansion, supported by growing investments from both public and private sectors.
